Advertisement

Surgery Today

, Volume 42, Issue 3, pp 220–224 | Cite as

Implications of surgical intervention in the treatment of neuroblastomas: 20-year experience of a single institution

  • Tatsuro TajiriEmail author
  • Ryota Souzaki
  • Yoshiaki Kinoshita
  • Yuhki Koga
  • Aiko Suminoe
  • Toshiro Hara
  • Tomoaki Taguchi
Original Article

Abstract

Purpose

The implications of surgical intervention for neuroblastomas were assessed in one institution.

Methods

We analyzed the clinical characteristics and extension of resection in 123 pediatric patients with neuroblastoma diagnosed between 1985 and 2004.

Results

The 5-year survival rate of the 82 patients under 12 months of age, 59 of whom were treated with complete resection of the primary tumor, was 97%. The 5-year survival rate of the 41 patients over 12 months of age did not differ significantly according to whether complete (n = 19) or incomplete resection (n = 22) was performed (46 vs. 38%, respectively). No local recurrence was observed in ten patients over 12 months of age with stage 4 disease who underwent complete resection of the primary tumor; however, four of these ten patients died of metastatic recurrence.

Conclusion

Considering that the majority of infantile neuroblastomas in this study had favorable biology, complete resection might be unnecessary for patients under 12 years of age. For advanced neuroblastomas in patients over 12 months of age, the main treatment for metastasis is systemic chemotherapy, although extirpation of the primary tumor without extensive surgery might prevent local recurrence when combined with radiation therapy.

Keywords

Neuroblastoma Surgical intervention Biology 

Notes

Acknowledgments

This work was supported in part by a grant-in-aid for scientific research from the Japanese Society for the Promotion of Science.

References

  1. 1.
    Crist WM, Kun LE. Common solid tumors of childhood. N Engl J Med. 1991;324:461–71.PubMedCrossRefGoogle Scholar
  2. 2.
    Bodeur GM. Molecular basis for heterogeneity in human neuroblastoma. Eur J Cancer. 1995;31:505–10.CrossRefGoogle Scholar
  3. 3.
    Tajiri T, Shono K, Tanaka S, Suita S. Evaluation of genetic heterogeneity in neuroblastoma. Surgery (St. Louis). 2002;131:283–7.CrossRefGoogle Scholar
  4. 4.
    Kubota M. The role of surgery in the treatment of neuroblastoma. Surg Today. 2010;40:526–32.PubMedCrossRefGoogle Scholar
  5. 5.
    Tanaka S, Tajiri T, Noguchi S, Ihara K, Hara T, Suita S. Clinical significance of a highly sensitive analysis for gene dosage and the expression level of MYCN in neuroblastoma. J Pediatr Surg. 2004;39:63–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Brodeur GM, Pritchard J, Berthold F. Revision of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 1993;11:1466–77.PubMedGoogle Scholar
  7. 7.
    Matsumura T, Sawada T, Shikata T. New trend in treatment strategy for neuroblastoma infants in Japan. Proceedings of the 32nd Annual Meeting of American Society of Clinical Oncology. J Clin Oncol. 1996;15:461.Google Scholar
  8. 8.
    Iehara T, Hosoi H, Akazawa K, Matsumoto Y, Suita S, et al. MYCN gene amplification is a powerful prognostic factor even in infantile neuroblastoma detected by mass screening. Br J Cancer. 2006;94:1510–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Kaneko M, Tsuchida Y, Uchino J, Takeda T, Iwafuchi M, Ohnuma N, et al. Treatment results of advanced neuroblastoma with the First Japanese Study Group Protocol. J Pediatr Hematol Oncol. 1999;21:190–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Kaneko M, Tsuchida Y, Mugishima H, Ohnuma N, Yamamoto K, Kawa K, et al. Intensified chemotherapy increases the survival rates in state 4 neuroblastoma with MYCN amplification. J Pediatr Hematol Oncol. 2002;24:613–21.PubMedCrossRefGoogle Scholar
  11. 11.
    Brodeur GM, Maris JM, Yamashiro DJ. Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol. 1997;19:93–101.PubMedCrossRefGoogle Scholar
  12. 12.
    Suita S, Tajiri T, Kaneko M, Hirai M, Mugishima H, Sugimoto T, Tsuchida Y. Implications of MYCN amplification in patients with stage 4 neuroblastoma who undergo intensive chemotherapy. J Pediatr Surg. 2007;42:489–93.PubMedCrossRefGoogle Scholar
  13. 13.
    Suita S, Tajiri T, Higashi M, Tanaka S, Kinoshita Y, Takahashi Y, et al. Insights into infant neuroblastomas based on an analysis of neuroblastomas detected by mass screening at 6 months of age in Japan. Eur J Pediatr Surg. 2007;17:23–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Yamamoto K, Hanada R, Tanimura M, Aihara T, Hayashi Y. Natural history of neuroblastoma found by mass screening. Lancet. 1997;349:1102.PubMedCrossRefGoogle Scholar
  15. 15.
    Cecchetto G, Mosseri V, De Bernardi B. Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group. J Clin Oncol. 2005;23:8483–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Simon T, Hero B, Bohm GB, Schweinitz D, Berthold F. Review of image defined risk factors in localized neuroblastoma patients: results of the GPOH NB97 trial. Pediatr Blood Cancer. 2008;50:965–9.PubMedCrossRefGoogle Scholar
  17. 17.
    La Quaglia MP, Kushner BH, Heller G. Stage 4 neuroblastoma diagnosed at more than 1 year of age: gross total resection and clinical outcome. J Pediatr Surg. 1994;29:1162–6.PubMedCrossRefGoogle Scholar
  18. 18.
    Adkins ES, Sawin R, Gerbing RB, London WB, Matthay KK, Haase GM. Efficacy of complete resection for high risk neuroblastoma: a Children’s Cancer Group study. J Pediatr Surg. 2004;39:931–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Kuroda T, Saeki M, Honna T. Clinical significance of intensive surgery with intraoperative radiation for advanced neuroblastoma: does it really make sense? J Pediatr Surg. 2003;38:1735–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Castel V, Tovar JA, Costa E. The role of surgery in stage IV neuroblastoma. J Pediatr Surg. 2002;37:1574–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Kaneko M, Ohkawa H, Iwakawa M. Is extensive surgery required for treatment of advanced neuroblastoma? J Pediatr Surg. 1997;32:1616–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2012

Authors and Affiliations

  • Tatsuro Tajiri
    • 1
    Email author
  • Ryota Souzaki
    • 1
  • Yoshiaki Kinoshita
    • 1
  • Yuhki Koga
    • 2
  • Aiko Suminoe
    • 2
  • Toshiro Hara
    • 2
  • Tomoaki Taguchi
    • 1
  1. 1.Department of Pediatric Surgery, Graduate School of Medical SciencesKyushu UniversityFukuokaJapan
  2. 2.Department of Pediatrics, Graduate School of Medical SciencesKyushu UniversityFukuokaJapan

Personalised recommendations